A significant portion of the health burden of diabetic kidney disease (DKD) is caused by both
type 1 and type 2 diabetes which leads to morbidity and mortality globally. It is one of the …

Background We investigated a cross-sectional metabolomic analysis of plasma and urine of
patients with early and late stage diabetes associated chronic kidney disease (CKD) …

Kidney diseases (KD), a major public health problem that affects about 10% of the general
population, manifest in progressive loss of renal function, which ultimately leads to complete …

Chronic kidney disease (CKD), characterized as renal dysfunction, is recognized as a major
public health problem with high morbidity and mortality worldwide. Unfortunately, there are …

Background: There is a continuous rise in the prevalence of type 2 diabetes mellitus (T2DM)
worldwide and most patients are unaware of the presence of this chronic disease at the …

Diseases of the kidney are difficult to diagnose and treat. This review summarises the
definition, cause, epidemiology and treatment of some of these diseases including chronic …

A critical issue in the management of chronic kidney disease (CKD) is to prevent patients
from the progression to end-stage kidney disease (ESKD), however, there is only limited …

Diabetic kidney disease (DKD) is one of the most common diabetic complications, as well as
the leading cause of chronic kidney disease and end-stage renal disease around the world …

This review discusses the influence of gut microbiota dysbiosis on diabetic kidney disease
through metabolite profile changes and immune and inflammatory mechanisms. We also …

Metabolomics—the nontargeted measurement of all metabolites produced by the body—is
beginning to show promise in both biomarker discovery and, in the form of …